DC Investments Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,318
Closed -$485K 275
2019
Q3
$485K Buy
+15,318
New +$603K 0.28% 138

Other funds holding HCAT

DC Investments Management's HCAT Position: Q4 2019 in Review

DC Investments Management sold out of Health Catalyst (HCAT) in Q4 2019, closing a stake of 15,318 shares — an estimated $485K sold.

DC Investments Management first reported a position in HCAT in Q3 2019 and held it in 1 quarter. The position peaked at $485K in Q3 2019. 88 funds tracked by Wall St. Rank hold HCAT as of Q4 2019.

  • DC Investments Management reported no remaining Health Catalyst position as of Q4 2019 after selling out during the quarter.
  • DC Investments Management sold 15,318 Health Catalyst shares in Q4 2019, an estimated $485K.
  • DC Investments Management first reported a position in Health Catalyst in Q3 2019 and held it in 1 quarter.
  • DC Investments Management's Health Catalyst position peaked at $485K in Q3 2019.
  • 88 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2019.

Based on DC Investments Management's 13F filing for Q4 2019, filed 7 Feb 2020.